Treatment of Enterococcal Infections
General Principles
- The American Heart Association recommends treating E. faecalis infections with ampicillin or amoxicillin as first-line therapy, while E. faecium infections require vancomycin or newer agents like linezolid or daptomycin due to intrinsic penicillin resistance 1, 2
E. faecalis Treatment Approach
- Ampicillin 2 g IV every 4-6 hours is the gold standard for susceptible E. faecalis infections, as most strains retain ampicillin susceptibility 2, 3
- For serious infections requiring bactericidal activity, combine ampicillin with gentamicin for synergy, with native valve endocarditis treated for 4-6 weeks and prosthetic valve endocarditis treated for a minimum of 6 weeks 1, 4
- Only 3% of E. faecalis strains are multidrug-resistant, and many vancomycin-resistant E. faecalis remain penicillin-susceptible 1
E. faecium Treatment Approach
- Intrinsic penicillin resistance is common in E. faecium, making ampicillin ineffective as first-line therapy 1
- Up to 95% of E. faecium strains express multidrug resistance to vancomycin, aminoglycosides, and penicillins 1
- Linezolid 600 mg IV/PO every 12 hours is the preferred agent for vancomycin-resistant E. faecium, with proven clinical efficacy 1, 3
- Daptomycin 8-12 mg/kg/day IV is an alternative option for vancomycin-resistant E. faecium 1, 3
Aminoglycoside Resistance Patterns
- For strains with high-level aminoglycoside resistance, the double β-lactam regimen is reasonable for E. faecalis endocarditis 1
- Aminoglycoside resistance is increasingly common in both species, limiting traditional synergistic combinations 2
Critical Pitfalls to Avoid
- Never use cephalosporins alone for enterococcal coverage, as they have no intrinsic activity despite in vitro synergy when combined with ampicillin 3
- Do not assume E. faecium has the same susceptibility profile as E. faecalis, as E. faecium requires different empiric coverage due to intrinsic resistance 1
- Always obtain infectious disease consultation for enterococcal endocarditis management as standard of care 4
Duration of Therapy
- Uncomplicated infections should be treated for 7-14 days 2
- Endocarditis or serious infections require a minimum of 4-6 weeks of treatment 2, 4
- Prosthetic valve involvement requires a minimum of 6 weeks of treatment 1, 4
Treatment of Enterococcus faecalis Infections
Introduction to Therapeutic Approach
- The European Society of Cardiology suggests that amoxicillina may be preferred over ampicillina due to lower minimum inhibitory concentrations (MIC) 5
Considerations for Treatment
- For symptomatic balanitis with a positive culture, treatment is indicated, and local hygiene measures should be associated with treatment, including gentle washes with saline or delicate antiseptics 6
- The American Heart Association recommends against prescribing vancomycin empirically for E. faecalis, as ampicillina is superior and vancomicina should be reserved for patients with documented beta-lactam allergy 7
Ongoing Management
- It is essential to verify the antibiogram and adjust therapy when culture and sensitivity results are available 6
- For recurrent infections, consider local predisposing factors such as phimosis, poor hygiene, or diabetes 6
- The Infectious Diseases Society of America recommends checking the antibiogram and considering resistance or alternative diagnosis if there is no clinical improvement after 48-72 hours of therapy 6
Management of Enterococcus faecalis Bacteremia
Initial Empiric Therapy
- Begin treatment with ampicillin 2 g IV every 4 hours plus gentamicin 3 mg/kg/day IV divided into three doses while awaiting susceptibility results. 8
- Adding gentamicin provides synergistic bactericidal activity in serious bloodstream infections. [8][9]
- Target gentamicin peak concentrations of 3–4 µg/mL and trough concentrations < 1 µg/mL to optimize efficacy and limit toxicity. 10
Duration of Therapy Based on Source
- For native‑valve endocarditis, treat for 4 weeks if symptoms have been present < 3 months before diagnosis, or for 6 weeks if symptoms ≥ 3 months. 8
- For prosthetic‑valve endocarditis, a minimum of 6 weeks of therapy is required. [11][8]
Alternative Regimens When Standard Therapy Is Contraindicated
Penicillin Allergy (documented by skin testing)
- Use vancomycin 30 mg/kg/day IV in two divided doses (target trough 10–20 µg/mL) plus gentamicin 3 mg/kg/day for 6 weeks. [10][11]
- Ampicillin‑gentamicin is superior to vancomycin‑gentamicin and carries a lower risk of nephro‑ and ototoxicity. 11
High‑Level Aminoglycoside Resistance (HLAR)
- Administer ampicillin 200 mg/kg/day IV in 4–6 divided doses plus ceftriaxone 2 g IV every 12 hours for 6 weeks. [11][12]9
- This double‑β‑lactam regimen avoids aminoglycoside toxicity while providing efficacy comparable to ampicillin‑gentamicin. 12
- The ampicillin‑ceftriaxone combination demonstrated no nephrotoxicity, compared with a 23 % nephrotoxicity rate for ampicillin‑gentamicin. 12
Gentamicin‑Resistant but Streptomycin‑Susceptible Strains
- Use ampicillin 2 g IV every 4 hours plus streptomycin 15 mg/kg/day IV or IM in two divided doses (target peak 20–35 µg/mL, trough < 10 µg/mL). 11
- Avoid streptomycin when creatinine clearance is < 50 mL/min because of the risk of irreversible ototoxicity. 11
Rare β‑Lactamase‑Producing E. faecalis
- Treat with ampicillin‑sulbactam 3 g IV every 6 hours plus gentamicin. [10][11]
Critical Monitoring Parameters
- Monitor renal function and aminoglycoside serum levels closely, especially in older adults (median age ≈ 70 years in key trials). 12
- In patients with baseline renal impairment (creatinine clearance 30–50 mL/min), consider limiting gentamicin duration to 2 weeks to reduce nephrotoxicity. 8
- When vancomycin is used, maintain trough concentrations of 10–20 µg/mL. 10